Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain reduction methods during retinopathy of prematurity examination
IRCT20211225053512N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of Sucrose in retinopathy of prematurity (ROP) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Reduction of eye examination pain. Started Dec 2022; status: completed.
02
Drugs
Sucrose
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on IRCT20211225053512N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211225053512N1.